Compare HROW & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | SHO |
|---|---|---|
| Founded | 1998 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2008 | 2004 |
| Metric | HROW | SHO |
|---|---|---|
| Price | $30.61 | $11.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $65.00 | $11.96 |
| AVG Volume (30 Days) | 486.5K | ★ 1.6M |
| Earning Date | 11-09-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $1,115,167,000.00 |
| Revenue This Year | $28.81 | $2.47 |
| Revenue Next Year | $53.97 | N/A |
| P/E Ratio | ★ N/A | $50.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.54 | $8.69 |
| 52 Week High | $54.98 | $12.07 |
| Indicator | HROW | SHO |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 49.85 |
| Support Level | $28.54 | $10.99 |
| Resistance Level | $35.43 | $11.19 |
| Average True Range (ATR) | 1.25 | 0.17 |
| MACD | -0.21 | 0.03 |
| Stochastic Oscillator | 11.48 | 57.58 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.